Videos

Advice for Future Patients and Caregivers in TNBC

August 17th 2021

Latasha Jordan and Aditya Bardia, M.D., MPH, share advice for patients and caregivers on the importance of a positive outlook and attitude when living with triple-negative breast cancer.

Social Support Systems for Patients With TNBC

August 17th 2021

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

Safety and Efficacy of Sacituzumab Govitecan

August 17th 2021

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

The ASCENT 3 Trial of Sacituzumab Govitecan for TNBC

August 17th 2021

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.

Considerations for Referral After Progression of TNBC

August 17th 2021

A patient with triple-negative breast cancer, Latasha Jordan, reflects on the mental and emotional challenges she faced when she learned of her disease progression and shares her positive experience with physician referral thereafter.

Active Surveillance for Disease Progression in TNBC

August 17th 2021

A leader in breast oncology and a triple-negative breast cancer survivor discuss the role of active surveillance for post-surgical disease progression and emphasize the importance of support from health care providers after recurrence.

Surgical Options for Triple-Negative Breast Cancer

August 17th 2021

Aditya Bardia, M.D., MPH, and triple-negative breast cancer survivor, Latasha Jordan, discuss the importance of shared decision-making when considering mastectomy or lumpectomy and radiation for triple-negative breast cancer.

Neoadjuvant Chemotherapy for TNBC

August 17th 2021

Latasha Jordan discusses her experience with neoadjuvant chemotherapy, and an expert in the management of breast cancer, Aditya Bardia, M.D., MPH, reviews common side events associated with systemic treatment.

Longest Living Person to Receive Gleevec for Leukemia Shares Advice

August 16th 2021

Mel Mann, the longest living person who participated in the clinical trial for Gleevec – which was approved by the FDA just over 20 years ago – shares what he would tell his younger self.

How a Cancer Survivor Trained for ‘American Ninja Warrior’ During Treatment

August 16th 2021

Liposarcoma survivor Arianne Missimer discusses the training process for ‘American Ninja Warrior’ and how she felt the day of competition.

Educated Patient® Lung Cancer Summit Basics of Lung Cancer Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

Educated Patient® Lung Cancer Summit Targeted Treatment Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

Educated Patient® Lung Cancer Summit Looking Ahead Session: August 14, 2021

August 14th 2021

View the full CURE Educated Patient Lung Cancer Summit on demand.

Cancer Care in LGBTQ Patients: Where We Are and What We Need

August 9th 2021

More people are aware of the disparities LGBTQ patients face, but prohibitive legislature could be moving the needle backward when it comes to equality in care.

Survivor Turns Negative Thoughts Into Laughable Moments During Cancer Treatment

August 6th 2021

A survivor shares how she chose to approach her mindset during cancer treatments to keep herself from spiraling.

Educated Patient® Leukemia Summit: July 31, 2021

August 3rd 2021

View the full CURE Educated Patient Leukemia Summit on demand.

Coping With a Leg Amputation and Segregation During Cancer Treatment at Age 9

August 2nd 2021

A survivor of osteosarcoma who underwent treatment in the 1960s in a segregated hospital ward, shares how he was able to find strength during that time.

Understanding MPN Symptom Management

July 30th 2021

CURE spoke with Dr. Rajiit Rampal, on behalf of the MPN Research Foundation, about MPN symptoms and their management.

Helping Patients With MPNs to Elevate Their Voice

July 30th 2021

CURE spoke with Brandon Goetzman, board member from the MPN Research Foundation, on elevating the patient’s voice when it comes to their care for myeloproliferative neoplasms.

Highlighting the Need for Clinical Trial Education in MPNs

July 30th 2021

CURE spoke with Dr. Gabriela Hobbs, on behalf of the MPN Research Foundation, about the need for clinical trial education for patients with myeloproliferative neoplasms.

Educating Patients on MPN Disease Progression

July 30th 2021

CURE spoke with Dr. Rajiit Rampal, on behalf of the MPN Research Foundation, about disease progression in myeloproliferative neoplasms.

Discussing MPN Treatment Options

July 30th 2021

CURE spoke with Dr. Gabriela Hobbs, on behalf of the MPN Research Foundation, about currently available treatment options, as well as those under clinical investigation, for patients with myeloproliferative neoplasms.

Voice Actor Discusses the ‘Platinum Lining’ Behind His Throat Cancer Diagnosis

July 30th 2021

Rob Paulsen is the voice behind many beloved cartoon characters, but after receiving a cancer diagnosis, he discovered a whole new way to relate to others.

Precision Medicine and Clinical Trials

July 28th 2021

Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.

Biomarker Testing: Centralized Vs Local Labs

July 28th 2021

The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.

Role of Combination Therapy in RCC Management

July 27th 2021

Dr Thomas E. Hutson comments on the rationale for using combination immune therapy, as well as a combination of immune therapy and an oral VEGF inhibitor for initial treatment of RCC.

Managing Adverse Events in RCC

July 27th 2021

Kidney cancer expert, Dr Thomas E. Hutson, shares insight on managing adverse events resulting from combination therapy in RCC.

Common Questions on Medical Marijuana

July 26th 2021

An expert discusses the most common reasons his patients ask him about medical marijuana.

Access to Molecular Testing in the Community

July 21st 2021

Current barriers that impact patient access to comprehensive biomarker testing in the community and efforts underway to help advocate for increased accessibility to molecular assays moving forward.

Becoming Informed About Comprehensive Genomic Profiling

July 21st 2021

Resources available to support patients and community oncologists who are interested in learning more and gaining access to comprehensive biomarker testing.